Fertility Preservation in Breast Cancer Patients

• Status: Active, not recruiting
• Trial end date: 2022-12-01
• Target enrollment: 0
• Participant gender: Female

Summary

The purpose of this study is to evaluate efficiency and safety of controlled ovarian stimulation (COS) associated with an aromatase inhibitor (letrozole) for fertility preservation in breast cancer patients.

• Phase: Phase 4
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Erasme University Hospital
• Treatments: Letrozole

Criteria

Inclusion Criteria:

• Breast cancer female patients of less than 41 years old

• Addressed to fertility preservation Unit before starting chemotherapy

Exclusion Criteria:

• Metastatic breast cancer

• Known premature ovarian failure

• Basal FSH > 20IU

• Surgical contra-indications